Credit Agricole’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
OIM
BC
CS
CC
ACH
NCGI
Credit Agricole's AXDX Position: Q4 2017 in Review
Credit Agricole sold out of Accelerate Diagnostics (AXDX) in Q4 2017, closing a stake of 18,849 shares — an estimated $4.23M sold.
Credit Agricole first reported a position in AXDX in Q4 2016 and held it in 4 quarters. The position peaked at $4.23M in Q3 2017. 118 funds tracked by Wall St. Rank hold AXDX as of Q4 2017.
- Credit Agricole reported no remaining Accelerate Diagnostics position as of Q4 2017 after selling out during the quarter.
- Credit Agricole sold 18,849 Accelerate Diagnostics shares in Q4 2017, an estimated $4.23M.
- Credit Agricole first reported a position in Accelerate Diagnostics in Q4 2016 and held it in 4 quarters.
- Credit Agricole's Accelerate Diagnostics position peaked at $4.23M in Q3 2017.
- 118 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2017.
Based on Credit Agricole's 13F filing for Q4 2017, filed 13 Feb 2018.